Carbidopa and levodopa 50 mg/1
Carbidopa and levodopa · TABLET, EXTENDED RELEASE · Advagen Pharma Ltd
Carbidopa and levodopa is a tablet, extended release containing carbidopa and levodopa at 50 mg/1, taken oral. Manufactured by Advagen Pharma Ltd.
Key Facts
- Brand Name
- Carbidopa and levodopa
- Generic Name
- Carbidopa and levodopa
- NDC Code (Product)
72888-156- Manufacturer
- Advagen Pharma Ltd
- Strength
- 50 mg/1
- Dosage Form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- ANDA217482
- Drug Class
- Aromatic Amino Acid [EPC]; Aromatic Amino Acid Decarboxylation Inhibitor [EPC]
- Marketing Start
- 06/04/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Carbidopa and levodopa used for?
Carbidopa and levodopa contains Carbidopa and levodopa. It is a tablet, extended release taken oral. Consult your doctor for specific uses.
Is Carbidopa and levodopa a controlled substance?
Carbidopa and levodopa is not classified as a controlled substance by the DEA.
What is the generic name for Carbidopa and levodopa?
The generic name for Carbidopa and levodopa is Carbidopa and levodopa. There are 12 other brand versions of Carbidopa and levodopa.
What is the NDC code for Carbidopa and levodopa 50 mg/1?
The NDC (National Drug Code) for Carbidopa and levodopa 50 mg/1 is 72888-156, listed by Advagen Pharma Ltd.
Other Carbidopa Brands
See all →- Carbidopa-levodopa10 mg/172888-106
- Carbidopa and Levodopa10 mg/10615-8555
- CARBIDOPA AND LEVODOPA10 mg/131722-381
- CARBIDOPA AND LEVODOPA10 mg/147335-186
- Carbidopa and Levodopa25 mg/150228-458
- Carbidopa and Levodopa25 mg/159651-457
- Carbidopa and Levodopa25 mg/160687-661
- Carbidopa and Levodopa25 mg/160687-836
- RYTARY23.75 mg/164896-661
- CREXONT52.5 mg/164896-968
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)